Abdul W. Basit Livres

3D printing is set to transform the pharmaceutical sector, impacting medicine development, manufacturing, and usage. Its applications range from pre-clinical drug development and dosage design to creating functional implants and regenerative medicine. This volume serves as a comprehensive resource for those interested in adopting 3D printing technologies in pharmaceuticals, emphasizing their clinical translation. It features contributions from leading experts who provide in-depth information on various 3D printing techniques, current technologies in the pharmaceutical manufacturing supply chain, and highlights state-of-the-art medical applications while discussing regulatory aspects of modern drug product manufacture. The text is invaluable for academics and industry professionals, detailing both current and future uses of 3D printing in pharmaceuticals. Abdul W. Basit, a Professor of Pharmaceutics at UCL School of Pharmacy, leads a multidisciplinary research group focused on gastrointestinal physiology and its clinical implications. He has authored over 350 publications, holds 25 patents, and founded three pharmaceutical companies. Simon Gaisford, Chair in Pharmaceutics at UCL, specializes in innovative medicine manufacturing technologies, including ink-jet and 3D printing, and has published extensively in the field. Together, they contribute significantly to advancing pharmaceutical science and technology.